Archer Investment Corporation’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Archer Investment Corporation's DGX Position: Q2 2026 in Review
Archer Investment Corporation increased its Quest Diagnostics (DGX) stake by 0.43% in Q2 2026, buying an estimated $196 and bringing the position to 232 shares worth $49.1K. The position accounts for 0.01% of the portfolio, ranked #522.
Archer Investment Corporation first reported a position in DGX in Q4 2018 and has held it in 31 quarters since. The position peaked at $145K in Q4 2022. 802 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Archer Investment Corporation held 232 shares of Quest Diagnostics worth $49.1K as of Q2 2026.
- Archer Investment Corporation bought 1 Quest Diagnostics share in Q2 2026, an estimated $196.
- Quest Diagnostics made up 0.01% of Archer Investment Corporation's portfolio in Q2 2026, its #522 holding.
- Archer Investment Corporation first reported a position in Quest Diagnostics in Q4 2018 and has held it in 31 quarters since.
- Archer Investment Corporation's Quest Diagnostics position peaked at $145K in Q4 2022.
- 802 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.